Does TREPROSTINIL Cause Pulmonary arterial hypertension? 3,240 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 3,240 reports of Pulmonary arterial hypertension have been filed in association with TREPROSTINIL (TYVASO). This represents 3.5% of all adverse event reports for TREPROSTINIL.
3,240
Reports of Pulmonary arterial hypertension with TREPROSTINIL
3.5%
of all TREPROSTINIL reports
978
Deaths
2,289
Hospitalizations
How Dangerous Is Pulmonary arterial hypertension From TREPROSTINIL?
Of the 3,240 reports, 978 (30.2%) resulted in death, 2,289 (70.6%) required hospitalization, and 135 (4.2%) were considered life-threatening.
Is Pulmonary arterial hypertension Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TREPROSTINIL. However, 3,240 reports have been filed with the FAERS database.
What Other Side Effects Does TREPROSTINIL Cause?
Dyspnoea (16,348)
Headache (14,051)
Diarrhoea (11,335)
Nausea (10,320)
Cough (8,945)
Fatigue (7,440)
Dizziness (7,405)
Infusion site pain (5,169)
Vomiting (5,097)
Death (4,764)
What Other Drugs Cause Pulmonary arterial hypertension?
MACITENTAN (2,390)
AMBRISENTAN (1,965)
SELEXIPAG (1,387)
EPOPROSTENOL (1,055)
BOSENTAN (778)
TADALAFIL (680)
SILDENAFIL (487)
RIOCIGUAT (436)
ILOPROST (284)
BOSENTAN\BOSENTAN (245)
Which TREPROSTINIL Alternatives Have Lower Pulmonary arterial hypertension Risk?
TREPROSTINIL vs TREPROSTINIL DIOLAMINE
TREPROSTINIL vs TRETINOIN
TREPROSTINIL vs TRIAMCINOLONE
TREPROSTINIL vs TRIAMCINOLONE ACETONIDE
TREPROSTINIL vs TRIAMCINOLONE HEXACETONIDE